Inhibikase Therapeutics, Inc. · NASDAQ:IKT
Ra Capital Management, L.P. reported a 9.90% stake in Inhibikase Therapeutics, Inc. (Schedule 13G/A)
Event Jul 29, 2026 · Filed Jul 31, 2026
Ra Capital Management, L.P. reported a 9.90% stake in Inhibikase Therapeutics, Inc., 14,653,994 shares, as a passive investor on Jul 29, 2026. Filed Jul 31, 2026 (Schedule 13G/A).
- Stake
- 9.90%
- Shares
- 14,653,994
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 9.90% | 14,653,994 |
| Peter Kolchinsky | 9.90% | 14,653,994 |
| Rajeev Shah | 9.90% | 14,653,994 |
| RA Capital Healthcare Fund, L.P. | 9.90% | 14,653,994 |
Source
Related
- Inhibikase Therapeutics, Inc.
- Ra Capital Management, L.P.
- Inhibikase Therapeutics, Inc. shareholders
- Schedule 13G · Ra Capital Management, L.P. · Jul 17, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Sands Capital Life Sciences Pulse Fund II, L.P. · Aug 13, 2026
- Form 4 · Berman Dennis N · Jul 31, 2026
- Form 4 · RA Capital Healthcare Fund LP · Jul 31, 2026